|1.||Kesselheim, Aaron S: 4 articles (12/2015 - 04/2008)|
|2.||Choudhry, Niteesh K: 4 articles (07/2014 - 04/2008)|
|3.||Doloresco, Fred: 3 articles (06/2010 - 02/2008)|
|4.||Schumock, Glen T: 3 articles (06/2010 - 02/2008)|
|5.||Shah, Nilay D: 3 articles (06/2010 - 02/2008)|
|6.||Vermeulen, Lee C: 3 articles (06/2010 - 02/2008)|
|7.||Hunkler, Robert J: 3 articles (06/2010 - 02/2008)|
|8.||Hoffman, James M: 3 articles (06/2010 - 02/2008)|
|9.||Luo, Jing: 2 articles (12/2015 - 01/2014)|
|10.||Gidal, Barry E: 2 articles (12/2013 - 12/2008)|
|1.||Acquired Immunodeficiency Syndrome (AIDS)
03/01/2007 - "Generic drugs have the potential to cause harm if rigorous standards for their use are not followed, but those that are qualified offer great promise in the treatment of HIV/AIDS."
10/28/2004 - "Generic drugs allowed in global trial of AIDS therapy."
01/01/2014 - "In order for the AIDS treatment program to remain sustainable, efforts should be pursued to reduce prices through generic drugs, price negotiation and other public health flexibilities such as compulsory licensing."
11/01/2012 - "It is expected that the importance of compulsory licenses may grow in the future due to the loss of generic drugs sources after the introduction of pharmaceutical product patents in India, the continuing high prevalence of epidemics, such as of HIV/AIDS, in developing countries and the increase in noncommunicable diseases in these nations. "
07/01/2012 - "Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed."
|2.||Hypertension (High Blood Pressure)
08/01/2013 - "Generic drugs for hypertension: are they really equivalent?"
06/01/2007 - "Members paid no copayment for the generic samples and paid lower copayments throughout the continued use of the generic drugs for chronic conditions such as hypertension. "
03/01/2004 - "[Do generic drugs help control expenditure on hypertension? "
11/01/2010 - "[Influence of substitution of brand name for generic drugs on therapeutic compliance in hypertension and dyslipidemia]."
01/01/2008 - "Our data confirm that generic drugs adipin and normodipine are as effective and safe as original norvasc in treatment of patients with hypertension."
11/01/2008 - "These studies could bring consensus about the role of generic drugs for treating epilepsy."
04/01/2012 - "Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review."
01/01/2012 - "Although there is an established criterion of "bioequivalence" that generic formulations must demonstrate, narrow-therapeutic index drugs for sensitive clinical circumstances such as epilepsy, antiplatelet therapies, and mental health treatments may require different regulatory treatment than other generic drugs. "
12/01/2008 - "Debate: Substitution of generic drugs in epilepsy: is there cause for concern?"
11/01/2008 - "The use of generic drugs for treating epilepsy may, however, be more controversial. "
01/01/2012 - "Border seizures of generic drugs present human rights and trade institutions with a unique challenge. "
11/01/2011 - "Comparison of brand and generic drugs revealed no significant difference in seizure frequency; however, some prospective studies showed significant differences in PK parameters, primarily those not used for bioequivalence determinations. "
01/01/2010 - "Brazil and India file complaint against EU over seizure of generic drugs."
01/01/2009 - "Brazil and India clash with EU over seizure of generic drugs."
09/01/2010 - "The cause of the seizure might be a delay in taking medication or late redispensation, among others, but apparently the nature of the product dispensed is not relevant in this study; this may alleviate some of the concerns about generic drugs and epilepsy."
|5.||Substance-Related Disorders (Drug Abuse)
02/01/1990 - "After partial success in reducing antibiotic drug costs by traditional methods (i.e., closed formulary, use of generic drugs, retrospective drug usage review, continuing education), a study of a new "team approach" was implemented. "
07/01/2013 - "A substitution index that takes into account the maximum potential quantity-based share of generic drugs as a fairer measure may promote more realistic goals and encourage generic drug usage."
01/01/2013 - "The average number of drugs per prescription was 3.52±2.31; the average percentage of generic drugs, antibiotic usage, injection drug usage, and drugs prescribed from the national essential drug list were 96.12%, 29.90%, 20.02% and 48.85%, respectively. "
|2.||Anticonvulsants (Antiepileptic Drugs)
|3.||Angiotensin Receptor Antagonists
|1.||Drug Therapy (Chemotherapy)
|2.||Combination Drug Therapy (Combination Chemotherapy)